Voveran: Targeted Relief for Acute Pain and Inflammation
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.42 | $37.84 (0%) | 🛒 Add to cart |
| 120 | $0.40 | $50.45 $48.16 (5%) | 🛒 Add to cart |
| 180 | $0.38 | $75.68 $67.94 (10%) | 🛒 Add to cart |
| 270 | $0.36 | $113.52 $97.18 (14%) | 🛒 Add to cart |
| 360 | $0.36
Best per pill | $151.36 $129.00 (15%) | 🛒 Add to cart |
Synonyms | |||
Voveran (diclofenac) is a potent nonsteroidal anti-inflammatory drug (NSAID) specifically formulated to manage moderate to severe pain and inflammation associated with a variety of musculoskeletal and arthritic conditions. As a prescription medication, it works by inhibiting cyclooxygenase (COX) enzymes, thereby reducing the production of prostaglandins, which are key mediators of pain, fever, and inflammation. Its targeted mechanism offers a reliable therapeutic option for patients requiring effective symptomatic control, improving functional capacity and quality of life. Available in multiple formulations, including oral tablets, topical gels, and injectable solutions, Voveran provides flexibility in treatment regimens tailored to individual patient needs and clinical scenarios.
Features
- Active ingredient: Diclofenac sodium or potassium
- Drug class: Nonsteroidal anti-inflammatory drug (NSAID)
- Available formulations: Oral tablets (including delayed-release and extended-release), topical gel, suppositories, and injectable solution
- Mechanism of action: Reversible inhibition of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes
- Half-life: Approximately 2 hours (short-acting formulations)
- Bioavailability: ~50-60% (oral); variable for topical application
Benefits
- Provides rapid and effective relief from acute pain and inflammation
- Reduces stiffness and improves joint mobility in arthritic conditions
- Offers multiple administration routes for tailored therapeutic approaches
- Helps decrease dependency on opioid analgesics for moderate pain management
- Supports return to normal daily activities and physical function
- Topical formulation minimizes systemic exposure and gastrointestinal risks
Common use
Voveran is commonly prescribed for the management of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It is also indicated for acute musculoskeletal conditions such as sprains, strains, and tendinitis. Additionally, it may be used for postoperative pain, primary dysmenorrhea, and acute gout attacks. The choice of formulation—oral, topical, or injectable—depends on the severity of symptoms, patient comorbidities, and treatment goals as determined by a healthcare provider.
Dosage and direction
Dosage varies based on formulation and indication. For oral tablets in adults, the typical dose for osteoarthritis is 100-150 mg per day in divided doses. For rheumatoid arthritis, 150-200 mg per day in divided doses is common. Topical gel should be applied 4 times daily to the affected area, not exceeding 32 grams per day for all joints combined. Injectable formulations are administered via intramuscular injection, typically 75 mg once or twice daily. Always follow the specific prescribing instructions provided by a healthcare professional. Do not crush, chew, or split delayed-release tablets. Take oral forms with food or milk to minimize gastrointestinal upset.
Precautions
Use with caution in patients with a history of gastrointestinal ulceration or bleeding, cardiovascular disease, hypertension, renal impairment, or hepatic dysfunction. Avoid prolonged use without medical supervision. Patients should be monitored for signs of gastrointestinal bleeding, cardiovascular events, and renal or hepatic toxicity. Topical application should avoid contact with eyes, mucous membranes, or open wounds. Do not apply external heat or occlusive dressings over the topical gel. Sun exposure should be minimized due to potential photosensitivity reactions.
Contraindications
Voveran is contraindicated in patients with known hypersensitivity to diclofenac, aspirin, or other NSAIDs. It should not be used in individuals who have experienced asthma, urticaria, or allergic-type reactions after taking NSAIDs. Contraindications also include peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery, severe heart failure, active peptic ulcer disease, or gastrointestinal bleeding. Third trimester of pregnancy is an absolute contraindication due to risk of premature closure of the ductus arteriosus.
Possible side effect
Common side effects include nausea, dyspepsia, abdominal pain, diarrhea, and headache. Serious adverse effects may include gastrointestinal bleeding or perforation, cardiovascular thrombotic events (e.g., myocardial infarction or stroke), hypertension, heart failure, renal injury, hepatotoxicity, and severe skin reactions such as exfoliative dermatitis or Stevens-Johnson syndrome. Topical application may cause local reactions like dryness, itching, or rash at the site of application.
Drug interaction
Voveran may interact with anticoagulants (e.g., warfarin), antiplatelet agents, selective serotonin reuptake inhibitors (SSRIs), corticosteroids, other NSAIDs, ACE inhibitors, angiotensin II receptor blockers, diuretics, lithium, methotrexate, and cyclosporine. Concurrent use may increase the risk of bleeding, nephrotoxicity, or hepatotoxicity. Consult a healthcare provider before combining with any other medication, including over-the-counter products and herbal supplements.
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. Do not double the dose to make up for a missed one. For topical formulations, apply the missed dose as soon as possible and resume the regular schedule. Consistency in dosing is important for maintaining therapeutic effect, but occasional missed doses are unlikely to cause significant issues.
Overdose
Symptoms of overdose may include nausea, vomiting, epigastric pain, gastrointestinal bleeding, drowsiness, dizziness, tinnitus, or seizures. In severe cases, acute renal failure, respiratory depression, or coma may occur. There is no specific antidote; management is supportive and includes gastric lavage or activated charcoal if presented early. Hemodialysis is not effective due to high protein binding. Seek immediate medical attention or contact a poison control center in case of suspected overdose.
Storage
Store at room temperature (20-25°C or 68-77°F), away from light, moisture, and heat. Keep oral forms in their original container, tightly closed. Topical gel should not be frozen. Keep all medications out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Proper disposal of unused medication should follow local guidelines or take-back programs to prevent accidental ingestion or environmental contamination.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Do not disregard professional medical advice or delay in seeking it because of something you have read here. The use of Voveran should be under the supervision of a healthcare professional familiar with the patient’s medical history.
Reviews
Clinical studies and patient reports indicate that Voveran is effective in reducing pain and improving function in conditions like osteoarthritis and acute soft tissue injuries. Many patients experience significant relief within a few days of starting treatment. However, individual responses vary, and some report gastrointestinal discomfort, which may be mitigated with topical use or concomitant gastroprotective agents. Long-term users should be periodically evaluated for adverse effects. Always follow prescribed guidelines and report any unusual symptoms to your healthcare provider.